Oligomers Role in Seeding and Nucleating Amyloid Fibrils

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - January 31, 2009
Grant ID
A2005315
Co-Principal Investigator(s)
Summary
Aβ is one of many peptides and proteins associated with AD. Yet, while the peptides and proteins associated with these diseases are unique in sequence, recent evidence suggests that they share common pathways for aggregation, common structural features at each stage of aggregation, and perhaps common mechanisms of toxicity. The aggregation pathway contains intermediate conformations referred to as soluble spherical oligomers. Dr. Kayed will test hypotheses regarding the role of soluble oligomers in fibril formation. The long term goal of this project is to better understand the mechanisms of the process of amyloid fibril formation in order to effectively interrupt and/or hinder amyloid formation in AD and perhaps other degenerative diseases.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Circadian Rhythm Disruption and Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Ashish Sharma, PhD, MPharm
Current Organization
Washington University in St. Louis
Alzheimer's Disease Research
The Role of the Immune System in Driving Cognitive Decline
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Hannah Ennerfelt, PhD
Current Organization
Standford University